Pfizer vaccine second dose has 'sweet spot' after eight weeks, UK scientists say | Coronavirus | The Guardian
Spirulina platensis prevents oxidative stress and inflammation promoted by strength training in rats: dose-response relation study | Scientific Reports
COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR
Parents Grapple With How Long to Wait for Their Children's Second Shots - The New York Times
Your Questions On The COVID-19 Vaccine | SRUK
U.S. to recommend COVID-19 booster eight months after a second dose | Fortune
The Biden Administration May Recommend COVID Boosters After 8 Months - capradio.org
J&J Booster Raises Antibody Levels, Good After 8 Months: Study
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden - The Lancet
Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine | Nature Communications
Biden Administration Expected to Call for Covid-19 Vaccine Booster Shots - WSJ
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
CDC updates vaccine dose timing recommendation; Sanofi and GSK to seek FDA authorization for COVID-19 vaccine | AHA News
Second Covishield dose can be given between 8-16 weeks: NTAGI | Business Standard News
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden - The Lancet
U.S. Recommending Third Dose of COVID Vaccine After Eight Months | MDVIP
Clinical Guidance for COVID-19 Vaccination | CDC
China's COVID vaccines have been crucial — now immunity is waning
Czechs to offer booster vaccine shot to all after eight months | Reuters
Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects | Thorax
Millions of Americans Could Be Eligible for Covid Vaccine Booster - The New York Times
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
Pfizer testing 3rd COVID vaccine dose for kids under 5 after setback | The Times of Israel
